Slottsviken Fastighetsaktiebolag (publ), a real estate company, acquires, develops, and manages properties in Sweden and internationally. Its property portfolio includes residential properties; and commercial premises for production, shop/trade, restaurants, industry, workshops, logistics, and offices. The company also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities. The company was formerly known as Conpharm AB (publ) and changed its name to Slottsviken Fastighetsaktiebolag (publ) in July 2015. The company was incorporated in 1983 and is headquartered in Gothenburg, Sweden.
Metrics to compare | SLOTTb | Sector Sector - Average of metrics from a broad group of related Real Estate sector companies | Relationship RelationshipSLOTTbPeersSector | |
---|---|---|---|---|
P/E Ratio | 27.4x | −0.2x | 7.7x | |
PEG Ratio | 0.03 | 0.00 | 0.01 | |
Price/Book | 1.8x | 0.6x | 0.9x | |
Price / LTM Sales | 6.7x | 1.0x | 3.8x | |
Upside (Analyst Target) | - | 31.3% | 20.5% | |
Fair Value Upside | Unlock | 19.1% | 1.6% | Unlock |